Alpha-lactalbumin: Its production technologies and bioactive peptides

Comprehensive Reviews in Food Science and Food Safety

Volumn 9, Issue 2, 2010, Pages 197-212

  Kamau, Samuel Mburu ^a,b   Cheison, Seronei Chelulei ^c,d   Chen, Wei ^a   Liu, Xiao Ming ^a   Lu, Rong Rong ^a  

^a JIANGNAN UNIVERSITY   (China)

^b Dairy Training Institute   (Kenya)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d MASENO UNIVERSITY   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA-LACTALBUMIN; ALPHA-LACTALBUMINS; AMYLOID FIBRIL; ANTI-TUMORS; APOPTOSIS; BIOACTIVE PEPTIDES; DRAWING STRATEGY; ENZYME HYDROLYSIS; FUNCTIONAL FOODS; GLOBULAR PROTEINS; INFANT FORMULA; MEMBRANE SEPARATION; MINERAL BINDING; PLANT PROTEASE; PRODUCTION TECHNOLOGY;

CELL DEATH; DAIRY PRODUCTS; DRUG PRODUCTS; ENZYMES; HYDROLYSIS; MAMMALS; MICROFILTRATION; NANOTUBES; PEPTIDES;

LANTHANUM;

ANIMALIA; MAMMALIA;

EID: 78649380209     PISSN: None     EISSN: 15414337     Source Type: Journal    
DOI: 10.1111/j.1541-4337.2009.00100.x     Document Type: Article

References (122)

1. Ahmed SH, Saxena V, Miranda QR, inventors; Sepragen corporation, Hayward, assignee. 1998. Sequential separation of whey proteins and formulations thereof. US Patent 5,756,680.
2. Almaas H, Berner V, Holm H, Langsrud T, Vegarud GE. 2008. Degradation of whey from caprine milk by human proteolytic enzymes, and the resulting antibacterial effect against Listeria monocytogenes. Small Rumin Res 79:11-5.
3. Antila P, Paakkari I, Järvinen A, Mattila MJ, Laukkanen M, Pihlanto-Leppälä A. 1991. Opioid peptides derived from in vitro proteolysis of whey proteins. Int Dairy J 1:215-29.
4. Appel RD, Bairoch A, Hochstrasser DF. 1994. A new generation of information retrieval tools for biologists: the example of the expasy www Server. Trends Biochem Sci 19:258-60.
5. Barbana C, Pérez MD, Sánchez L, Dalgalarrondo M, Chobert JM, Haertlé T, Calvo M. 2006. Interaction of bovine α-lactalbumin with fatty acids as determined by partition equilibrium and fluorescence spectroscopy. Int Dairy J 16:18-25.
6. Barman TE. 1970. Purification and properties of bovine milk glyco-α-lactalbumin. Biochim Biophys Acta 214:242-4.
7. Barros RM, Extremina CI, Gonçalves IC, Braga BO, Balcão VM, Malcata FX. 2003. Hydrolysis of α-lactalbumin by cardosin A immobilized on highly activated supports. Enzyme Microb Technol 33:908-16.
8. Barros RM, Malcata FX. 2006. Molecular characterization of peptides released from β-lactoglobulin and α-lactalbumin via cardosins A and B. J Dairy Sci 89:483-94.
9. Baumy JJ, Brule G. 1988. Binding of bivalent cations to α-lactalbumin and β-lactoglobulin: effect of pH and ionic strength. Lait 68:33-48.
10. Bayram T, Pekmez M, Arda N, Yalçin AS. 2008. Antioxidant activity of whey protein fractions isolated by gel exclusion chromatography and protease treatment. Talanta 75:705-9.
11. Berkhout B, Derksen GCH, Back NKT, Klaver B, De Kruif CG, Visser S. 1997. Structural and functional analysis of negatively charged milk proteins with anti-HIV activity. AIDS Res Hum Retrov 13:1101-7.
12. Berthou J, Migliore-Samour D, Lifchitz A, Delettre J, Floch F, Jollès P. 1987. Immunostimulating properties and three-dimensional structure of two tripeptides from human and cow caseins. FEBS Lett 218:55-8.
13. Beulens JWJ, Bindels JG, de Graaf C, Alles MS, Wouters-Wesseling W. 2004. Alphalactalbumin combined with a regular diet increases plasma Trp-LNAA ratio. Physiol Behav 81: 585-93.
14. Biron E, Chatterjee J, Ovadia O, Langenegger D, Brueggen J, Hoyer D, Schmid HA, Jelinek R, Gilon C, Hoffman A, Kessler H. 2008. Improving oral bioavailability of peptides by multiple N-methylation: somatoastatin analogues. Angew Chem Int Ed 47: 2595-9.
15. Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee RK. 2003. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem 278:10993-1001.
16. Bordin G, Cordeiro Raposo F, de la Calle B, Rodriguez AR. 2001. Identification and quantification of major bovine milk proteins by liquid chromatography. J Chromatogr A 928:63-76.
17. Bottomley RC, inventor; Express foods group limited, assignee. 1991. Process for obtaining concentrates having a high alpha-lactalbumin content from whey. US Patent 5,008,376.
18. Bounous G, Kongshavn P. 1982. Influence of dietary proteins on the immune system of mice. J Nutr 112:1747-55.
19. Bramaud C, Aimar P, Daufin G. 1997. Optimisation of a whey protein fractionation process based on the selective precipitation of α-lactalbumin. Lait 77:411-23.
20. Brück WM, Kelleher SL, Gibson GR, Graverholt G, Lönnerdal BL. 2006. The effects of α-lactalbumin and glycomacropeptide on the association of CaCo-2 cells by enteropathogenic Escherichia coli, Salmonella Typhimurium and Shigella flexneri. FEMS Microbiol Lett 259:158-62.
21. Cheang B, Zydney AL. 2003. Separation of α-lactalbumin and β-lactoglobulin using membrane ultrafiltration. Biotechnol Bio Eng 83:201-9.
22. Cheison SC, Wang Z, Xu SY. 2007. Use of macroporous adsorption resin for simultaneous desalting and debittering of whey protein hydrolysates. Int J Food Sci Technol 42:1228-39.
23. Chowdrury FA, Raleigh DP. 2005. A comparative study of the α-subdomains of bovine and human α-lactalbumin reveals key differences that correlate with molten globule stability. Protein Sci 14:89-96.
24. Conrado LS, Veredas V, Nóbrega ES, Santana CC. 2005. Concentration of α-lactalbumin from cow milk whey through expanded bed adsorption using a hydrophobic resin. Braz J Chem Eng 22:501-9.
25. De-Laureto PP, Frare E, Gottardo R, Dael HV, Fontana A. 2002. Partly folded states of members of the lysozyme/lactalbumin superfamily: A comparative study by circular dichroism spectroscopy and limited proteolysis. Protein Sci 11:2932-46.
26. Didelot S, Bordenave-Juchereau S, Rosenfeld E, Fruitier-Arnaudin I, Piot JM, Sannier F. 2006. Preparation of angiotensin-I-converting enzyme inhibitory hydrolysates from unsupplemented caprine whey fermentation by various cheese microflora. Int Dairy J 16:976-83.
27. Eugenia Lucena M, Alvarez S, Menéndez C, Riera FA, Alvarez R. 2007. α-Lactalbumin precipitation from commercial whey protein concentrates. Sep Purif Technol 52:446-53.
28. Ferraretto A, Gravaghi C, Fiorilli A, Tettamanti G. 2003. Casein-derived bioactive phosphopeptides: role of phosphorylation and primary structure in promoting calcium uptake by HT-29 tumor cells. FEBS Lett 551:92-8.
29. Gauthier SF, Pouliot Y, Saint-Sauveur D. 2006. Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins. Int Dairy J 16:1315-23.
30. Graveland-Bikker JF, De Kruif CG. 2006. Unique milk protein-based nanotubes: food and nanotechnology meet. Trends Food Sci Technol 17:196-203.
31. Guo MR, Fox PF, Flynn A. 1995. Susceptibility of β-lactoglobulin and sodium caseinate to proteolysis by pepsin and trypsin. J Dairy Sci 78:2336-44.
32. Hammea V, Sanniera F, Piota JM, Didelota S, Bordenave-Juchereaua S. 2009. Crude goat whey fermentation by Kluyveromyces marxianus and Lactobacillus rhamnosus: contribution to proteolysis and ACE inhibitory activity. J Dairy Res 76:152-7.
33. Haque E, Chand R. 2008. Antihypertensive and antimicrobial bioactive peptides from milk proteins. Eur Food Res Technol 227:7-15.
34. Hartgerink JD, Granja JR, Milligan RA, Ghadiri MR. 1996. Self-assembling peptide nanotubes. J Am Chem Soc 118:43-50.
35. Hayes M, Ross RP, Fitzgerard GF, Stanton C. 2007. Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part 1: overview. Biotechnol J 2:426-34.
36. Hernández-Ledesma B, Valos AD, Bartolomé B, Amigo L. 2005. Preparation of antioxidant enzymatic hydrolysates from α-lactalbumin and β-lactoglobulin. Identification of active peptides by HPLC-MS. J Agric Food Chem 53:588-93.
37. Heine WE, Klein PD, Miyashita C, Inventors; Baylor college of medicine, assignee.1992. Method for isolating alpha-lactalbumin from whey. International patent Wo/1992/003468.
38. Ijäs H, Collin M, Finckenberg P, Pihlanto-Leppälä A, Korhonen H, Korpela R, Vapaatalo H, Nurminen ML. 2004. Antihypertensive opioid-like milk peptide α-lactorphin: lack of effect on behavioural tests in mice. Int Dairy J 14:201-5.
39. Indyk HE. 2009. Development and application of an optical biosensor immunoassay for α-lactalbumin in bovine milk. Int Dairy J 19:36-42.
40. Ipsen R, Otte J. 2007. Self-assembly of partially hydrolysed α-lactalbumin. Biotech Adv 25:602-5.
41. Jaziri M, Migliore SD, Casabianca MRP, Keddad K, Morgat JL, Jolles P. 1992. Specific binding sites on human phagocytic blood cells for Gly-Leu-Phe and Val-Glu-Pro-Ile-Pro-Tyr, immunostimulating peptides from human milk proteins. Biochim Biophys Acta 1160:251-61.
42. Kagan BL, Ganz T, Lehrer RI. 1994. Defensins: a family of antimicrobial and cytotoxic peptides. Toxicol 87:131-49.
43. Kamijima T, Ohmura A, Sato T, Akimoto K, Itabashi M, Mizuguchi M, Kamiya M, Kikukawa T, Aizawa T, Takahashi M, Kawano K, Demura M. 2008. Heat-treatment method for producing fatty acid-bound α-lactalbumin that induces tumor cell death. Biochem Biophys Res Commun 376:211-4.
44. Kanda Y, Hisayasu S, Abe Y, Katsura K, Mashimo K. 2007. Growth-active peptides are produced from α-lactalbumin and lysozyme. Life Sci 81:449-57.
45. Kayser H, Meisel H. 1996. Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins. FEBS Lett 383:18-20.
46. Kim SB, Seo IS, Khan MA, Ki KS, Lee WS, Lee HJ, Shin HS, Kim HS. 2007. Enzymatic hydrolysis of heated whey: Iron-binding ability of peptides and antigenic protein fractions. J Dairy Sci 90:4033-42.
47. Kim YJ, Nakatomi R, Akagi T, Hashikawa T, Takahashi R. 2005. Unsaturated fatty acids induce cytotoxic aggregate formation of amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutants. J Biol Chem 280:21515-21.
48. Knyazeva EL, Grishchenko VM, Fadeev RS, Akatov VS, Permyakov SE, Permyakov EA. 2008. Who is Mr. Hamlet? Interaction of human α-lactalbumin with monomeric oleic acid. Biochemistry 47:13127-37.
49. Koike H, Ito K, Miyamoto M, Nishino H. 1980. Effects of long-term blockade of angiotensin-converting enzyme with captopril (SQ14,225) on hemodynamics and circulating blood volume in SHR. Hypertension 2:299-303.
50. Konrad G, Kleinschmidt T. 2008. A new method for isolation of native α-lactalbumin from sweet whey. Int Dairy J 18:47-54.
51. Kuhlman CF, Lien E, Weaber J, O'Callaghan D, inventors; Wyeth, Madison, NJ (US), assignee. 2005. Infant formula compositions comprising increased amounts of alpha-lactalbumin. US Patent 6,913,778, B2.
52. Laureto PPD, Frare E, Battaglia F, Mossuto MF, Uversky VN, Fontana A. 2005. Protein dissection enhances the amyloidogenic properties of α-lactalbumin. FEBS J 272:2176-88.
53. Lee YM, Skurk T, Hennig M, Hauner H. 2007. Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. Eur J Nutr 46:21-7.
54. Lightfoot EN, inventor; Wisconsin Alumni Research Foundation, assignee. 2006. Membrane cascade-based separation. US Patent 7,141,171,B2.
55. Lönnerdal B, Lien EL. 2003. Nutritional and physiologic significance of α-lactalbumin in infants. Nutr Rev 61:295-305.
56. López-Expósito I, Recio I. 2008. Protective effect of milk peptides: antibacterial and antitumor properties. Adv Exp Med Biol 606:271-93.
57. López-Fandiño R, Otte J, van Camp J. 2006. Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. Int Dairy J 16:1277-93.
58. Lucas D, Rabiller-Baudry M, Millesime L, Chaufer B, Daufin G. 1998. Extraction of α-lactalbumin from whey protein concentrate with modified inorganic membranes. J Membr Sci 148:1-12.
59. Manji B, Hill A, Kakuda Y, Irvine DM. 1985. Rapid separation of milk whey proteins by anion exchange chromatography. J Dairy Sci 68:3176-9.
60. Markus CR, Jonkman LM, Lammers JHC, Deutz NEP, Messer MH, Rigtering N. 2005. Evening intake of α-lactalbumin increases plasma tryptophan availability and improves morning alertness and brain measures of attention. J Clin Nutr 81:1026-33.
61. Markus CR, Olivier B, Panhuysen GEM, Van Der Gugten J, Alles MS, Tuiten A, Westen-berg HGM, Fekkes D, Koppeschaar HF, De Haan E. 2000. The bovine protein {alpha}-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress. Am J Clin Nutr 71:1536-44.
62. Marshall K. 2004. Therapeutic applications of whey protein. Altern Med Rev 9:136-56.
63. Martins S, Sarmento B, Ferreira DC, Souto EB. 2007. Lipid-based colloidal carriers for peptide and protein delivery-liposomes versus lipid nanoparticles. Int J Nanomedicine 2:595-607.
64. Meisel H. 2005. Biochemical properties of peptides encrypted in bovine milk proteins. Curr Med Chem 12:1905-19.
65. Migliore-Samou D, Roch-Arveiller M, Tissot M, Jazziri MH, Keddad K, Giroud JP, Jollés P. 1992. Effects of tripeptides derived from milk proteins on polymorphonuclear oxidative and phosphoinositide metabolisms. Biochem Pharmacol 44:673-80.
66. Möller N, Scholz-Ahrens K, Roos N, Schrezenmeir J. 2008. Bioactive peptides and proteins from foods: indication for health effects. Eur J Nutr 47:171-82.
67. Moreno FJ, Mackie AR, Mills ENC. 2005. Phospholipids interactions protect the milk allergen α-lactalbumin from proteolysis during in vitro digestion. J Agric Food Chem 53:9810-6.
68. Mullally MM, Meisel H, FitzGerald RJ. 1996. Synthetic peptides corresponding to α-lactalbumin and β-lactoglobulin sequences with angiotensin-I-converting enzyme in-hibitory activity. Biol Chem Hoppe-Seyler 377:259-60.
69. Mullally MM, Meisel H, FitzGerald RJ. 1997. Angiotensin-I-converting enzyme inhibitory activities of gastric and pancreatic proteinase digests of whey proteins. Int Dairy J 7:299-303.
70. Muller A, Chaufer B, Merin U, Daufin G. 2003. Purification of α-lactalbumin from a prepurified acid whey: ultrafiltration or precipitation. Lait 83:439-51.
71. Muller A, Daufin G, Chaufer B. 1999. Ultrafiltration modes of operation for the separation of α-lactalbumin from acid casein whey. J Membr Sci 153:9-21.
72. Musaeva ARK, inventor; obschestvo s ogranichennoi otvetstvennostyu, assignee. 2005. Pharmaceutical anti-herpetic composition, method for producing a dosage form of thereon and method for use thereof. Russia Patent WO 2005/042015.
73. Neurath AR, Debnath AK, Strick N, Li YY, Lin K, Jiang S. 1995. Blocking of CD4 cell receptors for the human immunodeficiency virus type 1 (HIV-1) by chemically modified bovine milk proteins: potential for AIDS prophylaxis. J Mol Recognit 8:304-16.
74. Neyestani TR, Jalali M, Pezeshki M. 2003. Isolation of α-lactalbumin, β-lactoglobulin, and bovine serum albumin from cow's milk using gel filtration and anion-exchange chromatography including evaluation of their antigenicity. Protein Expr Purif 29:202-8.
75. N'Negue MA, Miclo L, Girardet JM, Campagna S, Mollé D, Gaillard JL. 2006. Proteolysis of bovine α-lactalbumin by thermolysin during thermal denaturation. Int Dairy J 16:1157-67.
76. 2+-dependent adsorption in hydrophobic expanded bed chromatography. Bioseparation 8:153-8.
77. Nurminen ML, Sipola M, Kaarto H, Pihlanto-Leppälä A, Piilola K, Korpela R, Tossavainen O, Korhonen H, Vapaatalo H. 2000. α-Lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci 66:1535-43.
78. Oevermann A, Engels M, Thomas U, Pellegrini A. 2003. The antiviral activity of naturally occurring proteins and their peptide fragments after chemical modification. Antiviral Res 59:23-33.
79. Orosco M, Rouch C, Beslot F, Feurte S, Regnault A, Dauge V. 2004. Alpha-lactalbuminenriched diets enhance serotonin release and induce anxiolytic and rewarding effects in the rat. Behav Brain Res 148:1-10.
80. Otte J, Ipsen R, Bauer R, Bjerrum MJ, Waninge R. 2005. Formation of amyloid-like fibrils upon limited proteolysis of bovine α-lactalbumin. Int Dairy J 15:219-29.
81. Otte J, Shalaby SM, Zakora M, Pripp AH, El-Shabrawy SA. 2007a. Angiotensin-converting enzyme inhibitory activity of milk protein hydrolysates: Effect of substrate, enzyme and time of hydrolysis. Int Dairy J 17:488-503.
82. Otte J, Shalaby SMA, Zakora M, Nielsen MS. 2007b. Fractionation and identification of ACE-inhibitory peptides from α-lactalbumin and β-casein produced by thermolysin-catalysed hydrolysis. Int Dairy J 17:1460-72.
83. Pellegrini A, Thomas U, Bramaz N, Hunziker P, Fellenberg RV. 1999. Isolation and identification of three bactericidal domains in the bovine α-lactalbumin molecule. Biochim Biophys Acta 1426:439-48.
84. Pellegrini A, Thomas U, Fellenberg RV, Wild P. 1992. Bactericidal activities of lysozyme and aprotinin against Gram-negative and Gram-positive bacteria related to their basic character. J Appl Microbiol 72:180-7.
85. Permyakov EA, Morozova LA Burstein EA. 1985. Cation binding effects on the pH, thermal and urea denaturation transitions in α-lactalbumin. Biophys Chem 21:21-31.
86. Permyakov SE, Pershikova IV, Khokhlova TI, Uversky VN, Permyakov EA. 2004. No need to be HAMLET or BAMLET to interact with histones: Binding of monomeric alpha-lactalbumin into histones and basic poly-amino acids. Biochemistry 43:5575-82.
87. Pihlanto-Leppälä A. 2001. Bioactive peptides derived from bovine whey proteins: opioid and ACE-inhibitory peptide. Trends Food Sci Technol 11:347-56.
88. Pihlanto-Leppälä A, Koskinen P, Piilola K, Tupasela T, Korhonen H. 2000. Angiotensin I-converting enzyme inhibitory properties of whey protein digest: concentration and characterisation of active peptides. J Dairy Res 67:53-64.
89. Pihlanto-Leppälä A, Marnila P, Hubert L, Rokka T, Korhonen HJT, Karp M. 1999. The effect of α-lactalbumin and β-lactoglobulin hydrolysates on the metabolic activity of Escherichia coli JM103. J Appl Microbiol 87:540-5.
90. Pihlanto A. 2006. Antioxidative peptides derived from milk proteins. Int Dairy J 16:1306-14.
91. Pintado ME, Malcata FX. 2000. Hydrolysis of ovine, caprine and bovine whey proteins by trypsin and pepsin. Bioprocess Biosyst Eng 23:275-82.
92. Pouliot Y, Wijers MC, Gauthier SF, Nadeau L. 1999. Fractionation of whey protein hydrolysates using charged UF/NF membranes. J Membr Sci 158:105-14.
93. Pripp H. 2008. Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials. Food Nutr Res 52:(10.3402/fnr.v52i0.1920).
94. Pripp AH, Isaksson T, Stepaniak L, Sørhaug T. 2004. Quantitative structure-activity relationship modeling of ACE-inhibitory peptides derived from milk proteins. Eur Food Res Technol 219:579-83.
95. Ramboarina SP, Redfield C. 2008. Probing the effect of temperature on the backbone dynamics of the human α-lactalbumin molten globule. J Am Chem Soc 130:15318-26.
96. Raviv U, Needleman DJ, Li Y, Miller HP, Wilson L, Safinya CR. 2005. Cationic liposome-microtubule complexes: Pathways to the formation of two-state lipid-protein nanotubes with open or closed ends. Proc Natl Acad Sci USA 102:11167-72.
97. Roser BJ, Sanderson I, Kampinga J, Colaco C, inventors; Quadrant Holdings Cambridge, Ltd., assignee. 2003. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery. US Patent 6,517,860,B1.
98. Saito T, Nakamura T, Kitazawa H, Kawai Y, Itoh T. 2000. Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. J Dairy Sci 83:1434-40.
99. Sandström O, Lönnerdal B, Graverholt G, Hernell O. 2008. Effects of α-lactalbumin-enriched formula containing different concentrations of glycomacropeptide on infant nutrition. Am J Clin Nutr 87:921-8.
100. Scanlon S, Aggeli A. 2008. Self-assembling peptide nanotubes. Nanotoday 3:3-4.
101. Schlothauer RC, Schollum LM, Reid JR, Harvey SA, Carr A, Fanshawe RL, inventors; New Zealand Dairy Board, assignee. 2003. Improved bioactive whey protein hydrolysate. New Zealand Patent WO/2000/042863A.
102. Schmidt DG, Meijer RJGM, Slangen CJ, Beresteijn ECH. 1995. Raising the pH of the pepsin-catalysed hydrolysis of bovine whey proteins increases the antigenicity of the hydrolysates. Clin Exp Allergy 25:1007-17.
103. Sozer N, Kokini JL. 2009. Nanotechnology and its applications in the food sector. Trends Biotechnol 27:82-9.
104. Suetsuna K, Ukeda H, Ochi H. 2000. Isolation and characterization of free radical scavenging activities peptides derived from casein. J Nutr Biochem 11:128-31.
105. Svanborg C, inventor; NYA Hamlet Pharm AB, Copenhagen Ø (DK), assignee. 2007. Active complex of alpha-lactalbumin (HAMLET) and cofactor. US patent 7,270,822,B2.
106. Svanborg C, Agerstam H, Aronson A, Bjerkvig R, Duringer C, Fischer W, Gustafsson L, Hallgren O, Leijonhuvud I, Linse S, Mossberg A, Nilsson H, Pettersson J, Svensson M. 2003. HAMLET kills tumor cells by an apoptosis-like mechanism-cellular, molecular, and therapeutic aspects. Adv Cancer Res 88:1-29.
107. Svenning C, Vegarud GE, editors. Proceeding of dairy foods in health conference; 1998; Wellington, New Zealand. IDF Nutrition Week.
108. Svensson M, Hakansson A, Mossberg AK, Linse S, Svanborg C. 2000. Conversion of alpha-lactalbumin to a protein inducing apoptosis. Proc Natl Acad Scie USA 97:4221-6.
109. Takano DT. 2002. Anti-hypertensive activity of fermented dairy products containing biogenic peptides. Antonie van Leeuwenhoek 82:333-40.
110. Tolkach A, Kulozik U. 2005. Fractionation of whey proteins and caseinomacropeptide by means of enzymatic crosslinking and membrane separation techniques. J Food Eng 67:13-20.
111. Tolkach A, Steinle S, Kulozik U. 2005. Optimization of thermal pretreatment conditions for the separation of native α-lactalbumin from whey protein concentrates by means of selective denaturation of β-lactoglobulin. J Food Sci 70:E557-66.
112. Tsai JS, Chen TJ, Pan BS, Gong SD, Chung MY. 2008. Antihypertensive effect of bioactive peptides produced by protease-facilitated lactic acid fermentation of milk. Food Chem 106:552-8.
113. Tsuruki T, Yoshikawa M. 2005. Anti-alopecia effect of Gly-Leu-Phe, an immunostimulating peptide derived from α-lactalbumin. Biosci Biotechnol Biochem 69:1633-5.
114. Vegarud GE, Langsrud T, Svenning C. 2000. Mineral-binding milk proteins and peptides: occurrence, biochemical and technological characteristics. Br J Nutr 84:91-8.
115. Vermeirssen V, Camp JV, Verstraete W. 2004. Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br J Nutr 92:357-66.
116. Walsh DM, Lomakin A, Benede GB, Condron MM, Teplow DB. 1997. Amyloid β-protein fibrillogenesis detection of a protofibrillar intermediate. J Biol Chem 272:22364-72.
117. Wu LC, Schulman BA, Peng ZY, Kim PS. 1996. Disulfide determinants of calcium-induced packing in α-lactalbumin. Biochemistry 35:859-63.
118. Xue Y, Liu JN, Sun Z, Ma Z, Wu C, Zhu D. 2001. α-Lactalbumin mutant acting as lysozyme. Proteins Struct Fun Gen 42:17-22.
119. Yang F, Zhang M, Chen J, Liang Y. 2006. Structural changes of α-lactalbumin induced by low PH and oleic acid. Biochim Biophys Acta 1764:1389-96.
120. Yang N, Strøm MB, Mekonnen SM, Svendsen JS, Rekdal Ø. 2004. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells. J Peptide Sci 10:37-46.
121. Ye X, Yoshida S, Ng TB. 2000. Isolation of lactoperoxidase, lactoferrin, α-lactalbumin, β-lactoglobulin B and β-lactoglobulin A from bovine rennet whey using ion exchange chromatography. Int J Biochem Cell Biol 32:1143-50.
122. Zhang M, Yang Jr F, Yang F, Chen J, Zheng CY, Liang Y. 2009. Cytotoxic aggregates of α-lactalbumin induced by unsaturated fatty acid induce apoptosis in tumor cells. Chem Biol Interact 180:131-42.